Saturday, July 4, 2026

Artiva to Advance NK Cell Therapy Into Phase 3 for Rheumatoid Arthritis After Positive Mid-Stage Data

GC Cell's Artiva Biotherapeutics advances NK cell therapy AlloNK to Phase 3 trials for rheumatoid arthritis after promising Phase 2 results.

New Satellite Images Reveal Unusual Activity in North Korea’s Capital

Speculations are rising that the new large...

ChatGPT Changed the Game—Now China’s AI Sector is Cooling Fast

Alibaba's Daniel Zhang warns of an AI infrastructure bubble as demand lags behind supply, impacting China's tech landscape.

Tag: alternative sources

No posts to display

Top News

- Our Sponsors Ad -

Follow us